Legacy of Innovation in Pediatric Oncology: Dr. Christopher Moertel Concludes Distinguished Career at the University of Minnesota
admin The University of Minnesota School of Medicine has announced the retirement of Dr. Christopher Moertel,...
admin
The Heart of the Hike How CureSearch Ultimate Hike Mobilizes Communities to Combat Childhood Cancer through Endurance and Philanthropy
The intersection of extreme physical endurance and medical philanthropy has carved a unique niche in...
Women’s Unyielding Spirit: Trailblazers in Science and Medicine Revolutionizing Cancer Research
The indelible contributions of women to the annals of science and medicine have consistently served...
Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
Shanghai-based Excalipoint Therapeutics has announced the successful closure of a substantial financing round totaling $68.7...
White House Proclaims September 2025 Childhood Cancer Awareness Month With New Focus on Environmental Toxins and Healthcare Price Transparency
On September 2, 2025, the White House issued an official proclamation designating September as Childhood...
Children’s Cancer Research Fund Announces Five New Major Research Grants to Combat Aggressive Pediatric Malignancies and Long-Term Health Challenges
The Children’s Cancer Research Fund (CCRF) has officially unveiled a new suite of research grants...
Love Resilience and a Shared Mission The Inspiring Journey of James and Elizabeth Gunnett and the Evolution of the CureSearch Ultimate Hike
In the landscape of modern philanthropy, few events combine physical endurance with emotional healing as...
Cancer Research Institute Launches Groundbreaking CRI Discovery Engine, Unifying Immunotherapy Data to Accelerate Cures
For more than seven decades, the Cancer Research Institute (CRI) has been at the forefront...
Spring Into Action Sports and Community Initiatives Drive Vital Funding for Pediatric Cancer Research and Innovation
As the transition from winter to spring marks a period of renewal across the United...
Pfizer’s Atirmociclib Shows Promising Advances in Breast Cancer Treatment, Signaling a Strategic Shift in Oncology Pipeline
A new drug from Pfizer, atirmociclib, is emerging as a critical component of the pharmaceutical...
